Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2011
At a glance
- Drugs Fluvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
- Focus Therapeutic Use
- 10 May 2010 Results presented at the 30th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
- 05 May 2009 Planned end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 05 May 2009 Actual patient number (56) added as reported by ClinicalTrials.gov.